title: Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth-retarded fetuses.
authors.forename: Diego
authors.initials: D
authors.lastname: Gazzolo
authors.forename: Matteo
authors.initials: M
authors.lastname: Bruschettini
authors.forename: Romolo
authors.initials: R
authors.lastname: Di Iorio
authors.forename: Emanuela
authors.initials: E
authors.lastname: Marinoni
authors.forename: Mario
authors.initials: M
authors.lastname: Lituania
authors.forename: Mauro
authors.initials: M
authors.lastname: Marras
authors.forename: Rossana
authors.initials: R
authors.lastname: Sarli
authors.forename: Pier Luigi
authors.initials: PL
authors.lastname: Bruschettini
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Michetti
mesh_terms: D001921:Brain / Q000196:embryology / Q000503:physiopathology; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D005315:Fetal Diseases / Q000097:blood; D005317:Fetal Growth Retardation / Q000097:blood* / Q000503:physiopathology; D005865:Gestational Age; D006801:Humans; D009569:Nitric Oxide / Q000008:administration & dosage*; D011247:Pregnancy; D009418:S100 Proteins / Q000097:blood*
chemical_list: D009418:S100 Proteins; D009569:Nitric Oxide